Literature DB >> 18673187

Epidemiology of HCV infection.

V Baldo1, T Baldovin, R Trivello, A Floreani.   

Abstract

It is estimated that approximately 130-170 million people worldwide are infected with hepatitis C virus (HCV). According to data from WHO community and blood donor surveys, the African and Eastern Mediterranean countries report the highest prevalence rates (>10%). The rates of infection in the general population and the incidence of newly-acquired cases indicate an appreciable change in the epidemiology of the infection in recent years. Prior to the widespread screening of blood donations, infected blood and blood products represented a common source of infection. On the other hand, the high peak in HCV antibodies among the elderly in Italian epidemiological studies on the population at large reflects a cohort effect due to an epidemic of HCV infection occurring after the Second World War. According to data reported by the CDC Surveillance System, the incidence of acute hepatitis C has declined since the late 1980s. In 2005, as in previous years, the majority of such cases in North America and Northern Europe occurred among young adults and injected drug use was the most common risk factor. Other, less commonly reported modes of HCV acquisition are occupational exposure to blood, high-risk sexual activity, tattooing, body piercing and other forms of skin penetration. Finally, the overall rate of mother-to-child transmission from HCV-infected, HIV-negative mothers has been estimated at around 5% (coinfection with HIV raises this figure to 19.4%). HCV prevention relies on identifying and counseling uninfected persons at risk of contracting hepatitis C.

Entities:  

Mesh:

Year:  2008        PMID: 18673187     DOI: 10.2174/138161208784746770

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  26 in total

1.  HCV and pregnancy: prevalence, risk factors, and pregnancy outcome in north Indian population: a case-control study.

Authors:  Lajya Devi Goyal; Sharanjit Kaur; Neerja Jindal; Harpreet Kaur
Journal:  J Obstet Gynaecol India       Date:  2014-06-15

2.  Optimization of Pharmacokinetics through Manipulation of Physicochemical Properties in a Series of HCV Inhibitors.

Authors:  Scott E Lazerwith; Gina Bahador; Eda Canales; Guofeng Cheng; Lee Chong; Michael O Clarke; Edward Doerffler; Eugene J Eisenberg; Jaclyn Hayes; Bing Lu; Qi Liu; Mike Matles; Michael Mertzman; Michael L Mitchell; Philip Morganelli; Bernard P Murray; Margaret Robinson; Robert G Strickley; Megan Tessler; Neeraj Tirunagari; Jianhong Wang; Yujin Wang; Jennifer R Zhang; Xubin Zheng; Weidong Zhong; William J Watkins
Journal:  ACS Med Chem Lett       Date:  2011-08-08       Impact factor: 4.345

3.  Prevalence and risk factors of asymptomatic hepatitis C virus infection in bangladesh.

Authors:  Fazal Karim; Graham Foster; Sm Fazle Akbar; Salimur Rahman
Journal:  J Clin Exp Hepatol       Date:  2011-08-26

4.  Gene therapeutic approach for inhibiting hepatitis C virus replication using a recombinant protein that controls interferon expression.

Authors:  Chul Hyun Joo; Uk Lee; Young Ran Nam; Jae U Jung; Heuiran Lee; Young Keol Cho; Yoo Kyum Kim
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

5.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

6.  Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes.

Authors:  Sandip K Bose; Keith Meyer; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts.

Authors:  Lisa Cukierman; Laurent Meertens; Claire Bertaux; Francis Kajumo; Tatjana Dragic
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Sarcoidosis and chronic hepatitis C: a case report.

Authors:  Vadim Brjalin; Riina Salupere; Valentina Tefanova; Kaiu Prikk; Natalia Lapidus; Enn Jõeste
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

9.  Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study.

Authors:  Basim M Ayesh; Sofia S Zourob; Salah Y Abu-Jadallah; Yonat Shemer-Avni
Journal:  Virol J       Date:  2009-07-16       Impact factor: 4.099

10.  Hepatitis C seroprevalence and associated risk factors, Anyang, China.

Authors:  Fangfang Liu; Ke Chen; Zhonghu He; Tao Ning; Yaqi Pan; Hong Cai; Yang Ke
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.